A clinical analysis of AIDS-related non-Hodgkin lymphoma in 5 patients and review of literature
10.3760/cma.j.issn.0578-1426.2012.03.003
- VernacularTitle:艾滋病合并非霍奇金淋巴瘤五例临床分析并文献复习
- Author:
Guiren RUAN
;
Huanling WANG
;
Ying GE
;
Xiaochun SHI
;
Fuping GUO
;
Dingrong ZHONG
;
Daobin ZHOU
;
Taisheng LI
- Publication Type:Journal Article
- Keywords:
Acquired immunodeficiency syndrome;
Lymphoma,non-Hodgkin;
Lymphoma,AIDS-related;
Retrospective studies
- From:
Chinese Journal of Internal Medicine
2012;51(3):184-187
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical characteristics of AIDS-related non-Hodgkin lymphoma(ARL)and review relative literature for the diagnosis and treatment of ARL.Method The clinical data of ARL patients admitted to Peking Union Medical College Hospital from April 2009 to April 2011 were retrospectively analyzed.Results Five male ARL patients aged 32 to 65 years old were included in this retrospective study.Among them,two patients were found to be HIV-positive for the first time,three were on regular highly active anti-retroviral therapy(HAART)for 7-8 months before the emergence of lymphoma-related symptoms.CD4+ T cell count was(69-232)× 106/L at presentation.Two patients firstly presented with sore throat and throat ulcer,one with cervical nodules,one with pelvic mass,one with fever and edema in right thigh.Through pathological analysis,four patients had B cell-originated lymphoma,with one Burkitt lymphoma and three diffuse large B cell lymphomas; one patient had T-cell lymphoma.Four patients were treated with chemotherapy,with one complete remission,one relapse,one non-response,and one death.One patient had radiotherapy only and had progressed disease.Bone marrow suppression and gastrointestinal disturbance were the main adverse effects of chemotherapy.Conclusions Lymphoma should be considered in any HIV-infected patients presented with unexplainable adenopathy,recurrent sore throat or throat ulcer,or fever of unknown origin.Biopsy should be rigorously carried out.Appropriate chemotherapy,together with HAART,may improve the prognosis greatly.
